73
Participants
Start Date
February 15, 2017
Primary Completion Date
October 15, 2023
Study Completion Date
October 15, 2023
Tesamorelin
Tesamorelin is an injectable medication already approved by the U.S. FDA to treat abdominal fat accumulation in HIV
Keck School of Medicine of the University of Southern California, Los Angeles
HIV Neurobehavioral Research Program (HNRP), San Diego
PalmTree, Palm Springs
University of California, San Francisco, San Francisco
Collaborators (1)
University of Southern California
OTHER
PalmTree Clinical Research Inc.
UNKNOWN
University of California, San Francisco
OTHER
University of California, San Diego
OTHER